Position in DSGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$8,495,091
+$1,260,598 QoQ
Shares Held
798,411
+3.5% QoQ
Ownership
1.28%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in DSGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,690,752,415 across 354 Biotechnology names. DSGN ranks #151 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in DSGN
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,495,091 | 798,411 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,234,493 | 771,268 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $5,578,592 | 740,849 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $3,205,537 | 951,198 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $3,659,472 | 948,050 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $5,873,111 | 951,882 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $4,458,217 | 828,665 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $271,403 | 81,016 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $315,714 | 78,341 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $209,381 | 79,012 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $165,336 | 70,058 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $4,017,951 | 637,770 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,527,100 | 957,903 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $11,486,449 | 1,119,537 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $18,105,452 | 1,082,862 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $14,377,160 | 1,026,940 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $16,591,960 | 1,027,366 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $21,410,000 | 1,000,000 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $14,690,000 | 1,000,000 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $19,890,000 | 1,000,000 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $29,900,000 | 1,000,000 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||